Rep. Dave Baker Meets Medical School Researchers Driven to End Addiction

Published by
Published by: 
Megan Zeiher, Sr. Communications Specialist
February 20, 2017

Representative Dave Baker from the Minnesota House of Representatives met with Dr. Tim Ebner, Head of the Medical School's Department of Neuroscience and a team of researchers to discuss the future of addiction research at the University of Minnesota. 

Rep. Baker toured the Wallin research building and Dr. Kevin Lim, Professor in the Department of Psychiatry, Dr. Mark J. Thomas, Associate Professor in the Department of Neuroscience, and Dr. Paul Pentel of the Hennepin County Medical Center shared their research advances.

Dr. Ebner and Rep. Baker also discussed the search for a leader of the Medical Discovery Team on Addiction. The Medical Discovery Team will be a world-class neuroscience-based translational program for the study of addiction. The state of Minnesota appropriated significant funds over the next ten years for the University of Minnesota Medical School to create Medical Discovery Teams focused on Addiction, Aging, Optical Imaging and Brain Science and Rural and American Indian Health Disparities

Substance abuse is the largest preventable cause of death in the United States. The University of Minnesota is driven to identify the root causes of relapse and create better painkillers to end addiction. Learn more about how University of Minnesota researchers are tackling addiction from every angle.

Share this post

Re. Dave Baker, family, and researchers
Representative Dave Baker touring a medical lab

You may also like:

The University of Minnesota Masonic Cancer Center has a new 13-member research team that will focus on microbiomes thanks to a new Chainbreaker grant.

There are currently more than 285,000 people in the United States suffering from spinal cord injuries, and about 17,000 new spinal cord injuries each year.

The number of Lyme disease cases has increased over the past two decades from roughly 300 cases in the mid-nineties to over 1,300 cases confirmed in 2016.